162 related articles for article (PubMed ID: 16542183)
1. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder.
Scarr E; Gray L; Keriakous D; Robinson PJ; Dean B
Bipolar Disord; 2006 Apr; 8(2):133-43. PubMed ID: 16542183
[TBL] [Abstract][Full Text] [Related]
2. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
[TBL] [Abstract][Full Text] [Related]
4. Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder.
Boer S; Berk M; Dean B
Neurosci Lett; 2009 Nov; 466(1):27-9. PubMed ID: 19765633
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia.
Dean B; Keriakous D; Scarr E; Thomas EA
Aust N Z J Psychiatry; 2007 Apr; 41(4):308-20. PubMed ID: 17464717
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
7. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.
Laifenfeld D; Karry R; Klein E; Ben-Shachar D
Biol Psychiatry; 2005 Apr; 57(7):716-25. PubMed ID: 15820228
[TBL] [Abstract][Full Text] [Related]
8. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
[TBL] [Abstract][Full Text] [Related]
9. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
[TBL] [Abstract][Full Text] [Related]
10. Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients.
Ding L; Hegde AN
Biol Psychiatry; 2009 Mar; 65(6):541-5. PubMed ID: 19041089
[TBL] [Abstract][Full Text] [Related]
11. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
13. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia.
Vawter MP; Hemperly JJ; Hyde TM; Bachus SE; VanderPutten DM; Howard AL; Cannon-Spoor HE; McCoy MT; Webster MJ; Kleinman JE; Freed WJ
Exp Neurol; 1998 Nov; 154(1):1-11. PubMed ID: 9875262
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
[TBL] [Abstract][Full Text] [Related]
15. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Asada T
Neurosci Res; 2004 Sep; 50(1):77-84. PubMed ID: 15288501
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
18. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
Karson CN; Mrak RE; Schluterman KO; Sturner WQ; Sheng JG; Griffin WS
Mol Psychiatry; 1999 Jan; 4(1):39-45. PubMed ID: 10089007
[TBL] [Abstract][Full Text] [Related]
19. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.
Sakai T; Oshima A; Nozaki Y; Ida I; Haga C; Akiyama H; Nakazato Y; Mikuni M
Neuropathology; 2008 Apr; 28(2):143-50. PubMed ID: 18069969
[TBL] [Abstract][Full Text] [Related]
20. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia.
Thompson PM; Sower AC; Perrone-Bizzozero NI
Biol Psychiatry; 1998 Feb; 43(4):239-43. PubMed ID: 9513732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]